Literature DB >> 21875919

Defining the disconnect between in vitro models and human arrhythmogenic disease: context matters.

Amy C Sturm, Peter J Mohler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21875919      PMCID： PMC3211044          DOI： 10.1161/CIRCULATIONAHA.111.051466

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene.

Authors:  Steven Poelzing; Cinzia Forleo; Melissa Samodell; Lynn Dudash; Sandro Sorrentino; Matteo Anaclerio; Rossella Troccoli; Massimo Iacoviello; Roberta Romito; Pietro Guida; Mohamed Chahine; Mariavittoria Pitzalis; Isabelle Deschênes
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690

2.  Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.

Authors:  Jonathan M Cordeiro; Hector Barajas-Martinez; Kui Hong; Elena Burashnikov; Ryan Pfeiffer; Anne-Marie Orsino; Yue Sheng Wu; Dan Hu; Josep Brugada; Pedro Brugada; Charles Antzelevitch; Robert Dumaine; Ramon Brugada
Journal:  Circulation       Date:  2006-10-30       Impact factor: 29.690

3.  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.

Authors:  Timothy M Olson; Virginia V Michels; Jeffrey D Ballew; Sandra P Reyna; Margaret L Karst; Kathleen J Herron; Steven C Horton; Richard J Rodeheffer; Jeffrey L Anderson
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

4.  Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model.

Authors:  Anne-Laure Leoni; Bruno Gavillet; Jean-Sébastien Rougier; Céline Marionneau; Vincent Probst; Solena Le Scouarnec; Jean-Jacques Schott; Sophie Demolombe; Patrick Bruneval; Christopher L H Huang; William H Colledge; Andrew A Grace; Hervé Le Marec; Arthur A Wilde; Peter J Mohler; Denis Escande; Hugues Abriel; Flavien Charpentier
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

5.  Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.

Authors:  Jamie D Kapplinger; David J Tester; Benjamin A Salisbury; Janet L Carr; Carole Harris-Kerr; Guido D Pollevick; Arthur A M Wilde; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2009-06-23       Impact factor: 6.343

6.  Genotype-phenotype aspects of type 2 long QT syndrome.

Authors:  Wataru Shimizu; Arthur J Moss; Arthur A M Wilde; Jeffrey A Towbin; Michael J Ackerman; Craig T January; David J Tester; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Elizabeth S Kaufman; Nynke Hofman; Takashi Noda; Shiro Kamakura; Yoshihiro Miyamoto; Samit Shah; Vinit Amin; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

7.  SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia.

Authors:  William P McNair; Lisa Ku; Matthew R G Taylor; Pam R Fain; Dmi Dao; Eugene Wolfel; Luisa Mestroni
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

8.  NOS1AP is a genetic modifier of the long-QT syndrome.

Authors:  Lia Crotti; Maria Cristina Monti; Roberto Insolia; Anna Peljto; Althea Goosen; Paul A Brink; David A Greenberg; Peter J Schwartz; Alfred L George
Journal:  Circulation       Date:  2009-10-12       Impact factor: 29.690

9.  A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill.

Authors:  W Antoinette Groenewegen; Mehran Firouzi; Connie R Bezzina; Saskia Vliex; Irene M van Langen; Lodewijk Sandkuijl; Jeroen P P Smits; Miriam Hulsbeek; Martin B Rook; Habo J Jongsma; Arthur A M Wilde
Journal:  Circ Res       Date:  2003-01-10       Impact factor: 17.367

10.  Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.

Authors:  Paola G Meregalli; Hanno L Tan; Vincent Probst; Tamara T Koopmann; Michael W Tanck; Zahurul A Bhuiyan; Frederic Sacher; Florence Kyndt; Jean-Jacques Schott; J Albuisson; Philippe Mabo; Connie R Bezzina; Herve Le Marec; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2008-11-11       Impact factor: 6.343
View more
  1 in total

1.  Analysis of SCN5A Gene Variants in East Slovak Patients with Cardiomyopathy.

Authors:  Mariana Priganc; Michaela Zigová; Iveta Boroňová; Jarmila Bernasovská; Dana Dojčáková; Viktória Szabadosová; Marta Mydlárová Blaščáková; Iveta Tóthová; Ján Kmec; Ivan Bernasovský
Journal:  J Clin Lab Anal       Date:  2016-08-24       Impact factor: 2.352
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.